CCR5 Promoter Polymorphism −2459G > A: Forgotten or Ignored?

CCR5/CXCR4 Dual Antagonism for the Improvement of HIV Infection Therapy

(2019) Fedora Grande et al.   MOLECULES

Transcriptional down-regulation of ccr5 in a subset of HIV+ controllers and their family members

(2019) Elena Gonzalo-Gil et al.   eLife

HIV-1 entry inhibitors: A review of experimental and computational studies

(2018) Tahere Mostashari Rad et al.   CHEMISTRY & BIODIVERSITY

Combination therapy with anti-HIV-1 antibodies maintains viral suppression

(2018) Pilar Mendoza et al.   NATURE

Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals

(2018) Yotam Bar-On et al.   NATURE MEDICINE

Human Genetic Variation and HIV/AIDS in Papua New Guinea: Time to Connect the Dots

(2018) Rajeev K. Mehlotra   Current HIV/AIDS Reports

Toward the Cure of HIV-1 Infection: Lessons Learned and Yet to be Learned as New Strategies are Developed

(2018) Jeffrey M. Jacobson et al.   AIDS REVIEWS

Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection

(2018) Alexander G. Allen et al.   Frontiers in Microbiology

Frequencies of gene variant CCR5-Δ32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers

(2017) Ute V. Solloch et al.   HUMAN IMMUNOLOGY

CCR5 expression, haplotype and immune activation in protection from infection in HIV-exposed uninfected individuals in HIV-serodiscordant relationships

(2017) Shameem Z. Jaumdally et al.   IMMUNOLOGY

Host and Viral Factors in HIV-Mediated Bystander Apoptosis

(2017) Himanshu Garg et al.   Viruses-Basel

CCR5 promoter activity correlates with HIV disease progression by regulating CCR5 cell surface expression and CD4 T cell apoptosis

(2017) Anjali Joshi et al.   Scientific Reports

CCR2 , CCR5 , and CXCL12 variation and HIV/AIDS in Papua New Guinea

(2015) Rajeev K. Mehlotra et al.   INFECTION GENETICS AND EVOLUTION

Medicinal Chemistry of Small Molecule CCR5 Antagonists for Blocking HIV-1 Entry: A Review of Structural Evolution

(2014) Ye Tian et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Association Between HIV-1 Tropism and CCR5 Human Haplotype E in a Caucasian Population

(2014) Kristi Huik et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

African Ancestry Influences CCR5 −2459G>A Genotype-Associated Virologic Success of Highly Active Antiretroviral Therapy

(2014) Vinay K. Cheruvu et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Host Genetic Factors Associated with Symptomatic Primary HIV Infection and Disease Progression among Argentinean Seroconverters

(2014) Romina Soledad Coloccini et al.   PLoS One

Chemokine (C-C Motif) Receptor 5 −2459 Genotype in Patients Receiving Highly Active Antiretroviral Therapy: Race-Specific Influence on Virologic Success

(2011) Rajeev K. Mehlotra et al.   JOURNAL OF INFECTIOUS DISEASES

A Randomized, Placebo Controlled, Double Masked Phase IB Study Evaluating the Safety and Antiviral Activity of Aprepitant, a Neurokinin-1 Receptor Antagonist in HIV-1 Infected Adults

(2011) Pablo Tebas et al.   PLoS One

Association of chemokine receptor gene (CCR2-CCR5) haplotypes with acquisition and control of HIV-1 infection in Zambians

(2011) Rakhi Malhotra et al.   Retrovirology

Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals

(2010) Mark M Manak et al.   AIDS